Global Active Pharmaceutical Ingredients Market Overview
APIs are chemical compounds or a combination of compounds that are used primarily to have the desired effect on biological systems. Excipients are inactive ingredients in a drug that are used to disperse APIs. APIs may be synthesized either through chemical or biotechnological methods.
Active Pharmaceutical Ingredients Market is expected to grow at a CAGR of 6.7% during the forecast period of 2018 to 2025.
Increasing incidence of age-related diseases is one of the prime factors driving the market growth. The implementation of stringent measures to prevent the penetration of counterfeit products by governments and regulatory agencies of many countries will curb the counterfeit products in the market, thereby driving the market for genuine products.
Moreover, The API industry is highly standardized in most regions, and the manufacturers are expected to adhere to the regulations imposed by many government agencies. Further, the approval process for manufacturing is extensive, and the strict adherence to the guidelines for manufacturing poses challenges to market growth. Also, fierce competition due to the presence of many vendors with similar offerings and declining investments in R&D owing to declining profit margins and the high failure rates of new products are some of the notable challenges in the market growth.
Global Active Pharmaceutical Ingredients Market – Production Process
By the production process, the market is bifurcated into synthetic and biotech ingredients. The synthetic type is expected to contribute to the growth of the API market, owing to its widespread adoption by various vendors. However, the biotechnology-based production process segment is expected to witness faster growth during the forecast period because of the increased demand for biotech drugs. The strong growth of the biotechnology industry and increased demand for biotechnology-based molecules have contributed to the growth of the market.
Geographically, the Global Active Pharmaceutical Ingredients Market is segmented into North America, Europe, Asia Pacific, and RoW. Among all the regions, Asia-Pacific is the fastest growing region in the global active pharmaceutical ingredient market owing to increasing healthcare expenditure, a large pool of patients, and the presence of a large pool of generic medicine producers.
Further, the active pharmaceutical ingredient market is growing due to increasing awareness of lifestyle associated diseases in developing countries such as China and India.
Some of the prominent players operating in the active pharmaceutical ingredients (API) market are BASF, DuPont, Bayer, Sun Pharma, and Dow Chemicals. The active pharmaceutical ingredients (API) market has consolidative vendor landscape owing to rigorous quality checks and numerous regulations imposed on the API, which is creating entry barriers to the new players.
In 2018, Olon SpA grew its global manufacturing presence by adding its first facility in Asia.
Why purchase the report?
- Detailed information of the Global API products across each segment, in terms of end-user highlighting the critical commercial assets and players.
- Recognize commercial opportunities in API products market by analyzing key trends and development.
- Extensive product benchmarking of all key players
- On-demand excel sheets and data tables.
- Raw Material Suppliers
- Product Manufacturers
- Industry Leaders/Investors/Key opinion leaders
- Research & Education Institutes
- Research Professionals
- Emerging Companies & Organizations
By Production Process
- Recombinant proteins
- Monoclonal antibodies
- North America
- Rest of the World
- Sun Pharma
- Dow Chemicals
- Teva Pharmaceutical Industries Ltd.
- WuXi AppTec
- Lonza Group
- Allergan plc
- Pfizer, Inc.